Geron (GERN) Depreciation and Depletion (2010 - 2021)
Geron recorded quarterly Depreciation and Depletion of $53000.0 in Q2 2021, up 10.42% quarter-over-quarter from $48000.0 in Q1 2021, and up 60.61% year-over-year from $33000.0 in Q2 2020.
Geron's Depreciation and Depletion history runs 12 years deep, the most recent figure standing at $53000.0 for Q2 2021.
- In Q2 2021, Depreciation and Depletion rose 60.61% year-over-year to $53000.0; the TTM figure through Jun 2021 stood at $199000.0 (up 103.06% YoY), while the FY2020 annual figure was $158000.0, up 146.88% from the prior year.
- Depreciation and Depletion came in at $53000.0 for Q2 2021 at Geron, up from $48000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $53000.0 in Q2 2021 to a low of $9000.0 in Q3 2019.
- A 5-year average of $25444.4 and a median of $19000.0 in 2017 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion slumped 35.71% in 2019 and soared 444.44% in 2020, its largest moves.
- Geron's Depreciation and Depletion stood at $19000.0 in 2017, then dropped by 26.32% to $14000.0 in 2018, then soared by 107.14% to $29000.0 in 2019, then jumped by 68.97% to $49000.0 in 2020, then gained by 8.16% to $53000.0 in 2021.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $53000.0, $48000.0, and $49000.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Geron | 846,759.37 | 846,759.37 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 53,000.00 |
| Jun 30, 2021 | 53,000.00 |
| Mar 31, 2021 | 48,000.00 |
| Mar 31, 2021 | 48,000.00 |
| Dec 31, 2020 | 49,000.00 |
| Dec 31, 2020 | 49,000.00 |
| Sep 30, 2020 | 49,000.00 |
| Sep 30, 2020 | 49,000.00 |
| Jun 30, 2020 | 33,000.00 |
| Jun 30, 2020 | 33,000.00 |
| Mar 31, 2020 | 27,000.00 |
| Mar 31, 2020 | 27,000.00 |
| Dec 31, 2019 | 29,000.00 |
| Dec 31, 2019 | 29,000.00 |
| Sep 30, 2019 | 9,000.00 |
| Sep 30, 2019 | 9,000.00 |
| Jun 30, 2019 | 11,000.00 |
| Jun 30, 2019 | 11,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Dec 31, 2018 | 14,000.00 |
| Dec 31, 2018 | 14,000.00 |
| Sep 30, 2018 | 14,000.00 |
| Sep 30, 2018 | 14,000.00 |
| Jun 30, 2018 | 15,000.00 |
| Jun 30, 2018 | 15,000.00 |
| Mar 31, 2018 | 16,000.00 |
| Mar 31, 2018 | 16,000.00 |
| Dec 31, 2017 | 19,000.00 |
| Dec 31, 2017 | 19,000.00 |
| Sep 30, 2017 | 19,000.00 |
| Sep 30, 2017 | 19,000.00 |
| Jun 30, 2017 | 18,000.00 |
| Jun 30, 2017 | 18,000.00 |
| Mar 31, 2017 | 20,000.00 |
| Mar 31, 2017 | 20,000.00 |
| Dec 31, 2016 | 18,000.00 |
| Dec 31, 2016 | 18,000.00 |
| Sep 30, 2016 | 21,000.00 |
| Sep 30, 2016 | 21,000.00 |
| Jun 30, 2016 | 21,000.00 |
| Jun 30, 2016 | 21,000.00 |
| Mar 31, 2016 | 21,000.00 |
| Mar 31, 2016 | 21,000.00 |
| Dec 31, 2015 | 17,000.00 |
| Dec 31, 2015 | 17,000.00 |
| Sep 30, 2015 | 17,000.00 |
| Sep 30, 2015 | 17,000.00 |
| Jun 30, 2015 | 13,000.00 |
| Jun 30, 2015 | 13,000.00 |
| Mar 31, 2015 | 9,000.00 |
| Mar 31, 2015 | 9,000.00 |
| Dec 31, 2014 | 9,000.00 |
| Dec 31, 2014 | 9,000.00 |
| Sep 30, 2014 | 9,000.00 |
| Sep 30, 2014 | 9,000.00 |
| Jun 30, 2014 | 14,000.00 |
| Jun 30, 2014 | 14,000.00 |
| Mar 31, 2014 | 15,000.00 |
| Mar 31, 2014 | 15,000.00 |
| Dec 31, 2013 | -37,000.00 |
| Dec 31, 2013 | -37,000.00 |
| Sep 30, 2013 | 93,000.00 |
| Sep 30, 2013 | 93,000.00 |
| Jun 30, 2013 | 122,000.00 |
| Jun 30, 2013 | 122,000.00 |
| Mar 31, 2013 | 142,000.00 |
| Mar 31, 2013 | 142,000.00 |
| Dec 31, 2012 | 172,000.00 |
| Dec 31, 2012 | 172,000.00 |
| Sep 30, 2012 | 193,000.00 |
| Sep 30, 2012 | 193,000.00 |
| Jun 30, 2012 | 214,000.00 |
| Jun 30, 2012 | 214,000.00 |
| Mar 31, 2012 | 251,000.00 |
| Mar 31, 2012 | 251,000.00 |
| Dec 31, 2011 | 344,000.00 |
| Dec 31, 2011 | 344,000.00 |
| Sep 30, 2011 | 402,000.00 |
| Sep 30, 2011 | 402,000.00 |
| Jun 30, 2011 | 416,000.00 |
| Jun 30, 2011 | 416,000.00 |
| Mar 31, 2011 | 418,000.00 |
| Mar 31, 2011 | 418,000.00 |
| Dec 31, 2010 | 401,000.00 |
| Dec 31, 2010 | 401,000.00 |
| Sep 30, 2010 | 404,000.00 |
| Sep 30, 2010 | 404,000.00 |